Please login to the form below

Not currently logged in
Email:
Password:

Novasep names Michel Spagnol CEO

Joins contract manufacturing firm from Shasun

Novasep Michel Spagnol Novasep has appointed Michel Spagnol as its new president and CEO, succeeding Patrick Glaser who returns to the US.

Spagnol joins French contract manufacturing firm Novasep from Shasun, where he was president and chief technology officer.

Prior to Shasun, Spagnol spent his career at Rhodia in Lyon, France and New Jersey, US, where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as sales and marketing vice president of Rhodia Pharma Solutions.  

He joins Novasep as the company looks to expand through investments in its manufacturing capabilities in both France and China.

“His track record in delivering customer driven solutions, his international and scientific background coupled with his extensive management experience, longstanding knowledge and relationships in the pharmaceutical industry will be strong assets for the company,” said Roger-Marc Nicoud, founder and non-executive chairman of the board of Novasep.

9th July 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics